Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.33 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29090137 | 0.98 | LMNA (0.42) | LMNATSHRMAPTCYP2D6ALDH1A1 | |
| SCHEMBL19864351 | 0.85 | LMNA (0.37) | LMNATSHRMAPTCYP2D6ALDH1A1 | |
| SCHEMBL229792 | 0.84 | TSHR (0.50) | LMNATSHRMAPTCYP2D6ALDH1A1 | |
| SCHEMBL28875912 | 0.81 | LMNA (0.48) | LMNATSHRMAPTCYP2D6ALDH1A1 | |
| SCHEMBL28727541 | 0.81 | LMNA (0.48) | LMNATSHRMAPTCYP2D6ALDH1A1 | |
| SCHEMBL18152012 | 0.81 | LMNA (0.48) | LMNATSHRMAPTCYP2D6ALDH1A1 | |
| SCHEMBL14095562 | 0.81 | LMNA (0.41) | LMNATSHRMAPTCYP2D6ALDH1A1 | |
| SCHEMBL7097260 | 0.81 | LMNA (0.41) | LMNATSHRMAPTCYP2D6ALDH1A1 | |
| SCHEMBL15437962 | 0.79 | FAAH (0.39) | LMNAMAPTEPHX2 | |
| SCHEMBL1012855 | 0.79 | LMNA (0.46) | LMNATSHRMAPTCYP2D6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230167310-A1 | CURING CATALYST AND RESIN COMPOSITION | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2023-06-01 | — | — | US | claimed |
| EP-4144436-A1 | CURING CATALYST AND RESIN COMPOSITION | Koei Chemical Company, Limited (JP) | 2023-03-08 | — | — | EP | claimed |
| CN-115461147-A | Curing catalyst and resin composition | 广荣化学株式会社 | 2022-12-09 | — | — | CN | claimed |
| US-12565595-B2 | Aqueous coating material composition and method for forming multilayer coating film | KANSAI PAINT CO., LTD. (JP) | 2026-03-03 | — | — | US | disclosed |
| US-20250346779-A1 | Method of Forming A Coating Film | KANSAI PAINT CO LTD (JP) | 2025-11-13 | — | — | US | disclosed |
| US-20250340751-A1 | Automobile Body Coating Method | KANSAI PAINT CO LTD (JP) | 2025-11-06 | — | — | US | disclosed |
| US-20250154374-A1 | AQUEOUS COATING MATERIAL COMPOSITION AND METHOD FOR FORMING MULTILAYER COATING FILM | KANSAI PAINT CO., LTD. (JP) | 2025-05-15 | — | — | US | disclosed |
| CN-113167961-B | Method for manufacturing polarizing film, optical film, and image display device | 日东电工株式会社 | 2025-02-28 | — | — | CN | disclosed |
| CN-116829662-B | Aqueous coating composition and method for forming multilayer coating film | 关西涂料株式会社 | 2024-10-29 | — | — | CN | disclosed |
| EP-3689476-B1 | METHOD FOR FORMING MULTILAYER COATING FILM | KANSAI PAINT CO LTD (JP) | 2024-10-02 | — | — | EP | disclosed |
| US-20240309239-A1 | AQUEOUS COATING MATERIAL COMPOSITION AND METHOD FOR FORMING MULTILAYER COATING FILM | KANSAI PAINT CO., LTD. (JP) | 2024-09-19 | — | — | US | disclosed |
| US-20090264654-A1 | PROCESS FOR THE PREPARATION OF PYRIMIDINE COMPOUNDS | ASTRAZENECA UK LIMITED (GB) | 2009-10-22 | — | — | US | disclosed |
| US-20090209693-A1 | Silver Beta-Ketocarboxylate, Material Comprising the Same for Forming Silver Metal, and Use Thereof | OSAKA INDUSTRIAL PROMOTION (JP) | 2009-08-20 | — | — | US | disclosed |
| EP-2088142-A2 | Compounds and Processes | AstraZeneca UK Limited (GB) | 2009-08-12 | — | — | EP | disclosed |
| US-7524955-B2 | Process for the preparation of pyrimidine compounds | ASTRAZENECA UK LIMITED (GB) | 2009-04-28 | — | — | US | disclosed |
| US-7524955-B2 | Process for the preparation of pyrimidine compounds | ASTRAZENECA UK LIMITED (GB) | 2009-04-28 | — | — | US | disclosed |
| EP-1905756-A1 | SILVER BETA-KETOCARBOXYLATE, MATERIAL COMPRISING THE SAME FOR FORMING SILVER METAL, AND USE THEREOF | OSAKA UNIVERSITY (JP) | 2008-04-02 | — | — | EP | disclosed |
| US-20060052604-A1 | Process for the Preparation of Pyrimidine Compounds | ASTRAZENECA UK LIMITED (GB) | 2006-03-09 | — | — | US | disclosed |
| EP-1578731-A2 | PROCESS FOR THE PREPARATION OF PYRIMIDINE COMPOUNDS | AstraZeneca UK Limited (GB) | 2005-09-28 | — | — | EP | disclosed |
| WO-2004054986-A2 | PROCESS FOR THE PREPARATION OF PYRIMIDINE COMPOUNDS | ASTRAZENECA UK LIMITED (GB) | 2004-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264654-A1 | PROCESS FOR THE PREPARATION OF PYRIMIDINE COMPOUNDS | DPYD, RIOX2, CCNE1 | LMNA 2945/4885TSHR 1719/4885MAPT 4839/4885 |
| US-12565595-B2 | Aqueous coating material composition and method for forming multilayer coating film | DRD2, CHRM1, PNMT | LMNA 963/4885TSHR 3087/4885MAPT 609/4885 |
| US-20090209693-A1 | Silver Beta-Ketocarboxylate, Material Comprising the Same for Forming Silver Metal, and Use Thereof | PCCA, BCKDK, MCCC2 | LMNA 2691/4885TSHR 4710/4885MAPT 910/4885 |
| US-20060052604-A1 | Process for the Preparation of Pyrimidine Compounds | DPYD, RIOX2, CCNE1 | LMNA 3041/4885TSHR 1722/4885MAPT 4836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.